Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…
Sun Pharmaceutical Industries
Read More
Novo Nordisk Rolls out Ozempic in India at ₹2,200 per Week Amid Patent Disputes
Novo Nordisk, the Denmark-based pharmaceutical major, has formally introduced its widely used diabetes and weight-management drug Ozempic in the Indian…